Cloned (Comment) | Organism |
---|---|
gene WARS, constitutive expression | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
A7D | site-directed mutagenesis, the mutant shows reduced induction of TNF-alpha and MIP-1alpha production compared to wild-type | Homo sapiens |
E11L | site-directed mutagenesis, the mutant shows reduced induction of TNF-alpha and MIP-1alpha production compared to wild-type | Homo sapiens |
E35G | site-directed mutagenesis, the mutant shows similar induction of TNF-alpha and MIP-1alpha production compared to wild-type | Homo sapiens |
L10D | site-directed mutagenesis, the mutant shows reduced induction of TNF-alpha and MIP-1alpha production compared to wild-type | Homo sapiens |
L22G | site-directed mutagenesis, the mutant shows reduced induction of TNF-alpha and MIP-1alpha production compared to wild-type | Homo sapiens |
L9D | site-directed mutagenesis, the mutant shows reduced induction of TNF-alpha and MIP-1alpha production compared to wild-type | Homo sapiens |
M42D | site-directed mutagenesis, the mutant shows reduced induction of TNF-alpha and MIP-1alpha production compared to wild-type | Homo sapiens |
additional information | generation of N-terminal 51 amino acid-deleted enzyme WRS mutant (mDELTAN51-WRS). The full-length wild-type enzyme, but not mini-WRS, activates macrophages to prime innate immune responses. The N-terminal 47 aa that are lacking in mini-WRS may be necessary for the correct orientation of the TLR4-MD2 dimers that is required for the activation of downstream signal pathways. Reduced levels of TNF-alpha and MIP-1alpha in culture supernatants of bone marrow derived macrophages treated with WRS enzyme mutants, except for mutant E35G causing slightly increased levels | Homo sapiens |
N152G | site-directed mutagenesis, the mutant shows reduced induction of TNF-alpha and MIP-1alpha production compared to wild-type | Homo sapiens |
N30G | site-directed mutagenesis, the mutant shows reduced induction of TNF-alpha and MIP-1alpha production compared to wild-type | Homo sapiens |
Q145G | site-directed mutagenesis, the mutant shows reduced induction of TNF-alpha and MIP-1alpha production compared to wild-type | Homo sapiens |
T18G | site-directed mutagenesis, the mutant shows reduced induction of TNF-alpha and MIP-1alpha production compared to wild-type | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
additional information | the full-length-WRS-induced TNF-alpha and MIP-1alpha production is significantly inhibited when TLR4, MD2, and TLR2 (to lesser degree) are suppressed | Homo sapiens | |
additional information | the full-length-WRS-induced TNF-alpha and MIP-1alpha production is significantly inhibited when TLR4, MD2, and TLR2 (to lesser degree) are suppressed | Mus musculus |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
cytoplasm | - |
Homo sapiens | 5737 | - |
cytoplasm | - |
Mus musculus | 5737 | - |
extracellular | the enzyme is secreted | Mus musculus | - |
- |
extracellular | the enzyme is secreted in N-terminal truncated form or in full-length form. The full-length wild-type enzyme, but not the short form, is rapidly secreted upon pathogen infection to prime innate immunity. Blood levels of full-length WRS are increased in sepsis patients, but not in those with sterile inflammation. Full-length WRS is secreted from monocytes and directly bound to macrophages via a toll-like receptor 4 (TLR4)-myeloid differentiation factor 2 (MD2) complex to induce phagocytosis and chemokine production | Homo sapiens | - |
- |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Mg2+ | required | Homo sapiens | |
Mg2+ | required | Mus musculus |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + L-tryptophan + tRNATrp | Homo sapiens | - |
AMP + diphosphate + L-tryptophyl-tRNATrp | - |
? | |
ATP + L-tryptophan + tRNATrp | Mus musculus | - |
AMP + diphosphate + L-tryptophyl-tRNATrp | - |
? | |
ATP + L-tryptophan + tRNATrp | Mus musculus C57BL/6 | - |
AMP + diphosphate + L-tryptophyl-tRNATrp | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P23381 | - |
- |
Mus musculus | P32921 | - |
- |
Mus musculus C57BL/6 | P32921 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
cell culture | peripheral blood mononuclear cells | Homo sapiens | - |
macrophage | - |
Homo sapiens | - |
macrophage | - |
Mus musculus | - |
monocyte | - |
Homo sapiens | - |
monocyte | - |
Mus musculus | - |
additional information | full-length WRS is secreted from monocytes and directly bound to macrophages via a toll-like receptor 4 (TLR4)-myeloid differentiation factor 2 (MD2) complex to induce phagocytosis and chemokine production | Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + L-tryptophan + tRNATrp | - |
Homo sapiens | AMP + diphosphate + L-tryptophyl-tRNATrp | - |
? | |
ATP + L-tryptophan + tRNATrp | - |
Mus musculus | AMP + diphosphate + L-tryptophyl-tRNATrp | - |
? | |
ATP + L-tryptophan + tRNATrp | - |
Mus musculus C57BL/6 | AMP + diphosphate + L-tryptophyl-tRNATrp | - |
? | |
additional information | potential complex formation between TLR4-MD2 and the WRS monomer, putative binding model of TLR4-MD2 with the enzyme WRS homodimer based on a protein-protein docking study, complex crystal structure analysis, overview | Homo sapiens | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
Tryptophanyl-tRNA synthetase | - |
Homo sapiens |
Tryptophanyl-tRNA synthetase | - |
Mus musculus |
WARS | - |
Homo sapiens |
WRS | - |
Homo sapiens |
WRS | - |
Mus musculus |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
ATP | - |
Homo sapiens | |
ATP | - |
Mus musculus |
General Information | Comment | Organism |
---|---|---|
malfunction | the full-length-WRS-induced TNF-alpha and MIP-1alpha production is significantly inhibited when TLR4, MD2, and TLR2 (to lesser degree) are suppressed, full-length-WRS-induced neutrophil infiltration is almost ablated in the TLR4-/- and MD2-/- mice, and partially reduced in TLR2-/- mice. Although truncated WRS mutant lacking N47 can bring the two TLR4-MD2 complexes into proximity through homodimerization of the WRS catalytic domain, it may not be able to induce the functional dimerization of TLR4-MD2 to activate downstream signalling | Mus musculus |
malfunction | the full-length-WRS-induced TNF-alpha and MIP-1alpha production is significantly inhibited when TLR4, MD2, and TLR2 (to lesser degree) are suppressed, human full-length-WRS-induced neutrophil infiltration is almost ablated in the TLR4-/- and MD2-/- mice, and partially reduced in TLR2-/- mice. Although truncated WRS mutant lacking N47 can bring the two TLR4-MD2 complexes into proximity through homodimerization of the WRS catalytic domain, it may not be able to induce the functional dimerization of TLR4-MD2 to activate downstream signalling | Homo sapiens |
physiological function | the secreted tryptophanyl-tRNA synthetase is a primary defence system against infection, it functions as an intrinsic defensive factor against infection. Administration of full-length murine WRS into Salmonella typhimurium-infected mice reduces the levels of bacteria and improves mouse survival, whereas its titration with the specific antibody aggravates the infection. Full-length WRS protects mice from typhimurium infection-induced lethality. The enzyme is secreted in N-terminal truncated form or in full-length form, the full-length wild-type enzyme, but not the short form, is rapidly secreted upon pathogen infection to prime innate immunity. Proposed working mechanism of full-length-WRS for TLR4-MD2 activation, overview | Mus musculus |
physiological function | the secreted tryptophanyl-tRNA synthetase is a primary defence system against infection, it functions as an intrinsic defensive factor against infection. Full-length WRS responds promptly to pathogens before the onset of innate immune responses. Prompt secretion of enzyme WRS from cultured human peripheral blood mononuclear cells (PBMCs) following infection with Salmonella typhimurium, Escherichia coli, Listeria monocytogenes, Staphylococcus aureus, and Candida albicans. Human full-length-WRS as an endogenous ligand of TLR4, which promptly triggers innate immunity against infection. Proposed working mechanism of full-length-WRS for TLR4-MD2 activation, overview | Homo sapiens |